PITTSBURGH – December 6, 2023 – A fast-dissolving vaginal insert that women would use at or around the time of sex as an “on-demand” HIV prevention method is being evaluated in a new early phase study ...

The landscape of HIV prevention has undergone a profound transformation with significant advancements in medical interventions and a deeper understanding of how the virus spreads. These developments ...

Despite the major advancements in HIV management, the global burden of HIV remains high with women continuing to bear the brunt of the epidemic. According to UNAIDS, globally, women accounted for 46 ...

The number of new HIV infections has fallen over the years – it declined by 39% from 2010 to 2023. But HIV’s devastating impact on global health persists. In 2023, 1.3 million people acquired HIV – ...

The injectable antiretroviral drug lenacapavir was safe and 100% effective as long-acting HIV pre-exposure prophylaxis (PrEP) among cisgender women in a Phase 3 clinical trial, according to top-line ...

A groundbreaking medical advancement could reshape the future of HIV prevention. In a landmark clinical trial, a twice-yearly injection of lenacapavir demonstrated an astonishing 96% effectiveness in ...

MEXICO CITY — It’s been called the closest the world has ever come to a vaccine against the AIDS virus. The twice-yearly shot was 100% effective in preventing HIV infections in a study of women, and ...

The critical need for accessible and controllable HIV prevention methods for women is particularly pronounced in Nigeria, which ranks third globally in the burden of the Human Immunodeficiency Virus ...

Jared Baeten, MD, PhD, discusses the significance of the PURPOSE 1 trial results, which found that lenacapavir for pre-exposure prophylaxis resulted in no new infections of HIV. How significant is it ...